The Semiconductor Industry Patent Scorecard

Every now and then, the Wall Street Journal features results from The Patent Board, which has developed more than 50 indicators that track global patent activity relating to companies' innovation, technology, and science strengths. Earlier in the week, the Wall Street Journal took a closer look at the semiconductor industry by profiling two leading innovators, Intel and Micron (see above graphic), and publishing a wealth of data about innovation performance within the semiconductor industry.


In terms of innovation cycle time and stock market performance, Intel appears to be out-competing Micron. However, when it comes to research intensity, Micron appears to be doing a better job of building on its core science capabilities. In another graphic (not included), Patent Board ranked the Top 10 semiconductor companies in terms of their technology strength, a factor that blends together qualities such as science strength, innovation cycle time and research intensity into an overall indication of the "scale, quality, impact and nearness to core science of a company's patent-based intellectual property":

  1. Intel
  • Micron
  • Broadcom
  • IBM
  • Texas Instruments
  • Samsung
  • Hitachi
  • Toshiba
  • Semiconductor Energy Lab
  • AMD
  • So far so good. Intel and Micron both score high in various categories and appear to be the innovation leaders. However, if you're like me, you'll probably find all these statistics a bit hard to decipher. First of all, the idea of linking "patent activity" to "innovation" is not always the most productive approach. The most innovative companies are not necessarily the ones with the biggest patent portfolios, as Booz Allen Hamilton has shown over and over again. Second of all, it seems like these "innovation rankings" fall apart when it comes to measuring stock market performance. (And these statistics were found in the "Money & Investing" section of the newspaper, so it's a safe bet that investors will use them to make stock picks)

    A naive investor, I suppose, would assume that the "most innovative" semiconductor companies are those that would turn in the best stock market performance. After all, these "innovative" companies keep coming up with cool new patents, which lead to cool new products, which lead to more revenue and increased cash flow. (QED!) However, that's not the case, as is seen in the final graphic provided by Patent Board.

    Intel, the anointed innovation leader when it comes to patent-based IP, actually has a stock price that has fallen by 1.3% over the past 52 weeks. Micron, the #2 pick, has fared even worse: its stock price has fallen by 22.9% over the past year. In contrast, companies further down the patent pecking order, like Infineon (+59.3%), FormFactor (+24.6%) and Taiwan Semi (+24.6%), have turned in stellar performance.

    At which point, of course, I throw my hands up, sell off my Intel position, say goodbye to AMD, and decide to invest in some high-growth, high-risk Taiwanese semiconductor plays.

    [graphic: The Patent Board in the Wall Street Journal]

    'Upstreamism': Your zip code affects your health as much as genetics

    Upstreamism advocate Rishi Manchanda calls us to understand health not as a "personal responsibility" but a "common good."

    Sponsored by Northwell Health
    • Upstreamism tasks health care professionals to combat unhealthy social and cultural influences that exist outside — or upstream — of medical facilities.
    • Patients from low-income neighborhoods are most at risk of negative health impacts.
    • Thankfully, health care professionals are not alone. Upstreamism is increasingly part of our cultural consciousness.
    Keep reading Show less

    In U.S. first, drug company faces criminal charges for distributing opioids

    It marks a major shift in the government's battle against the opioid crisis.

    George Frey/Bloomberg via Getty Images
    Politics & Current Affairs
    • The nation's sixth-largest drug distributor is facing criminal charges related to failing to report suspicious drug orders, among other things.
    • It marks the first time a drug company has faced criminal charges for distributing opioids.
    • Since 1997, nearly 222,000 Americans have died from prescription opioids, partly thanks to unethical doctors who abuse the system.
    Keep reading Show less

    Scientists create a "lifelike" material that has metabolism and can self-reproduce

    An innovation may lead to lifelike evolving machines.

    Shogo Hamada/Cornell University
    Surprising Science
    • Scientists at Cornell University devise a material with 3 key traits of life.
    • The goal for the researchers is not to create life but lifelike machines.
    • The researchers were able to program metabolism into the material's DNA.
    Keep reading Show less

    Calling out Cersei Lannister: Elizabeth Warren reviews Game of Thrones

    The real Game of Thrones might be who best leverages the hit HBO show to shape political narratives.

    Photo credit: Mario Tama / Getty Images
    Politics & Current Affairs
    • Sen. Elizabeth Warren argues that Game of Thrones is primarily about women in her review of the wildly popular HBO show.
    • Warren also touches on other parallels between the show and our modern world, such as inequality, political favoritism of the elite, and the dire impact of different leadership styles on the lives of the people.
    • Her review serves as another example of using Game of Thrones as a political analogy and a tool for framing political narratives.
    Keep reading Show less